Literature DB >> 20223998

Impaired organization and function of myofilaments in single muscle fibers from a mouse model of Pompe disease.

Sengen Xu1, Mikhail Galperin, Gary Melvin, Robert Horowits, Nina Raben, Paul Plotz, Leepo Yu.   

Abstract

Pompe disease, a deficiency of lysosomal acid alpha-glucosidase, is a disorder of glycogen metabolism that can affect infants, children, or adults. In all forms of the disease, there is progressive muscle pathology leading to premature death. The pathology is characterized by accumulation of glycogen in lysosomes, autophagic buildup, and muscle atrophy. The purpose of the present investigation was to determine if myofibrillar dysfunction in Pompe disease contributes to muscle weakness beyond that attributed to atrophy. The study was performed on isolated myofibers dissected from severely affected fast glycolytic muscle in the alpha-glucosidase knockout mouse model. Psoas muscle fibers were first permeabilized, so that the contractile proteins could be directly relaxed or activated by control of the composition of the bathing solution. When normalized by cross-sectional area, single fibers from knockout mice produced 6.3 N/cm2 of maximum Ca2+-activated tension compared with 12.0 N/cm2 produced by wild-type fibers. The total protein concentration was slightly higher in the knockout mice, but concentrations of the contractile proteins myosin and actin remained unchanged. Structurally, X-ray diffraction showed that the actin and myosin filaments, normally arranged in hexagonal arrays, were disordered in the knockout muscle, and a lower fraction of myosin cross bridges was near the actin filaments in the relaxed muscle. The results are consistent with a disruption of actin and myosin interactions in the knockout muscles, demonstrating that impaired myofibrillar function contributes to weakness in the diseased muscle fibers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223998      PMCID: PMC2867540          DOI: 10.1152/japplphysiol.01253.2009

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  30 in total

1.  Structural characterization of weakly attached cross-bridges in the A*M*ATP state in permeabilized rabbit psoas muscle.

Authors:  S Xu; J Gu; G Melvin; L C Yu
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Structures of actomyosin crossbridges in relaxed and rigor muscle fibers.

Authors:  L C Yu; B Brenner
Journal:  Biophys J       Date:  1989-03       Impact factor: 4.033

3.  Analysis of equatorial x-ray diffraction patterns from muscle fibers: factors that affect the intensities.

Authors:  S Malinchik; L C Yu
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

4.  Evidence for cross-bridge attachment in relaxed muscle at low ionic strength.

Authors:  B Brenner; M Schoenberg; J M Chalovich; L E Greene; E Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  X-ray diffraction evidence for cross-bridge formation in relaxed muscle fibers at various ionic strengths.

Authors:  B Brenner; L C Yu; R J Podolsky
Journal:  Biophys J       Date:  1984-09       Impact factor: 4.033

6.  Equatorial x-ray diffraction from single skinned rabbit psoas fibers at various degrees of activation. Changes in intensities and lattice spacing.

Authors:  B Brenner; L C Yu
Journal:  Biophys J       Date:  1985-11       Impact factor: 4.033

7.  Enzyme replacement therapy in the mouse model of Pompe disease.

Authors:  N Raben; M Danon; A L Gilbert; S Dwivedi; B Collins; B L Thurberg; R J Mattaliano; K Nagaraju; P H Plotz
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

8.  Force measurements in skinned muscle fibres.

Authors:  D C Hellam; R J Podolsky
Journal:  J Physiol       Date:  1969-02       Impact factor: 5.182

9.  Characterization of radial force and radial stiffness in Ca(2+)-activated skinned fibres of the rabbit psoas muscle.

Authors:  B Brenner; L C Yu
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

10.  Shortening velocity and power output of skinned muscle fibers from mammals having a 25,000-fold range of body mass.

Authors:  C Y Seow; L E Ford
Journal:  J Gen Physiol       Date:  1991-03       Impact factor: 4.086

View more
  13 in total

Review 1.  Pros and cons of different ways to address dysfunctional autophagy in Pompe disease.

Authors:  Jeong-A Lim; Naresh Kumar Meena; Nina Raben
Journal:  Ann Transl Med       Date:  2019-07

2.  Therapeutic Benefit of Autophagy Modulation in Pompe Disease.

Authors:  Jeong-A Lim; Baodong Sun; Rosa Puertollano; Nina Raben
Journal:  Mol Ther       Date:  2018-05-03       Impact factor: 11.454

3.  Improved efficacy of a next-generation ERT in murine Pompe disease.

Authors:  Su Xu; Yi Lun; Michelle Frascella; Anadina Garcia; Rebecca Soska; Anju Nair; Abdul S Ponery; Adriane Schilling; Jessie Feng; Steven Tuske; Maria Cecilia Della Valle; José A Martina; Evelyn Ralston; Russell Gotschall; Kenneth J Valenzano; Rosa Puertollano; Hung V Do; Nina Raben; Richie Khanna
Journal:  JCI Insight       Date:  2019-03-07

4.  Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease.

Authors:  Nina Raben; Cynthia Schreiner; Rebecca Baum; Shoichi Takikita; Sengen Xu; Tao Xie; Rachel Myerowitz; Masaaki Komatsu; Jack H Van der Meulen; Kanneboyina Nagaraju; Evelyn Ralston; Paul H Plotz
Journal:  Autophagy       Date:  2010-11       Impact factor: 16.016

Review 5.  Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.

Authors:  Nina Raben; Amanda Wong; Evelyn Ralston; Rachel Myerowitz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

Review 6.  Autophagy in lysosomal storage disorders.

Authors:  Andrew P Lieberman; Rosa Puertollano; Nina Raben; Susan Slaugenhaupt; Steven U Walkley; Andrea Ballabio
Journal:  Autophagy       Date:  2012-05-01       Impact factor: 16.016

7.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

Review 8.  Manifestations of Age on Autophagy, Mitophagy and Lysosomes in Skeletal Muscle.

Authors:  Matthew Triolo; David A Hood
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

9.  Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice.

Authors:  Darin J Falk; Meghan S Soustek; Adrian Gary Todd; Cathryn S Mah; Denise A Cloutier; Jeffry S Kelley; Nathalie Clement; David D Fuller; Barry J Byrne
Journal:  Mol Ther Methods Clin Dev       Date:  2015-03-25       Impact factor: 6.698

10.  Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1).

Authors:  Rosie J Naylor; Leanda Livesey; John Schumacher; Nicole Henke; Claire Massey; Kenny V Brock; Marta Fernandez-Fuente; Richard J Piercy
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.